Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Presentation at NMS 2014 highlights growing dangers of non-steroidal anti-inflammatory drugs

A presentation at this week’s National Medicines Symposium in Brisbane has highlighted the dangers of people taking common medicines such as non-steroidal anti-inflammatories (NSAIDs) without thinking about the potential risks or harms.

23 May 2014

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

23 May 2014

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

EKF, confirms scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease.

From EKF Diagnostics 23 May 2014

Kidney transplant recipients live longer than patients on intensive home hemodialysis

A first-ever study from a large Canadian centre found that kidney transplant recipients lived longer and had better treatment success than patients on intensive home hemodialysis, but also had an increased risk of being hospitalized within the first year.

23 May 2014

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the EnligHTN III study, which found the company's second-generation EnligHTN™ renal denervation system provided safe and effective therapy for patients with drug-resistant, uncontrolled hypertension six months post-procedure. The results were presented during a hot line late-breaking clinical trial session at EuroPCR 2014.

22 May 2014

Professor receives grant to study stress-induced hypertension, its effects on neuroimmune system

Paul Marvar, Ph.D., assistant professor of pharmacology and physiology at the George Washington University School of Medicine and Health Sciences, was awarded a $721,435 grant from the National Heart, Lung, and Blood Institute to study stress-induced hypertension and its effects on the neuroimmune system.

22 May 2014

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

21 May 2014

Renal dysfunction affects NT-proBNP predictive thresholds in pulmonary hypertension

N-terminal pro-brain natriuretic peptide remains a valid predictor in patients with pulmonary arterial hypertension who have concomitant renal dysfunction, say researchers.

19 May 2014

Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.

19 May 2014

First Edition: May 16, 2014

Today's headlines include reports about the Indiana governor's alternative plan to expand Medicaid. Kaiser Health News staff writer Sarah Varney, working in collaboration with PBS Newshour, reports: "Men and women involved in the criminal justice system are more likely to be sicker than the general population, with higher rates of diabetes, hypertension, depression, mood disorders and alcohol and drug addiction.

16 May 2014

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.

16 May 2014

Walking shown to improve clinical outcomes in patients with kidney disease

A recent study indicates that walking can reduce the risks of premature death and the need for dialysis or kidney transplant among patients with kidney disease.

16 May 2014

OxThera granted new patents for treatment of hyperoxaluria

OxThera AB announced today that it has been granted two new US patents and one new Australian patent during the last year.

15 May 2014

Fourteen businesses receive innovative funding to improve kidney care

NEW ideas and technologies that could prevent kidney disease, allow earlier diagnosis and give patients greater independence are to be developed thanks to an innovative funding competition developed.

From Randox Laboratories Ltd. 15 May 2014

DaVita wins 2014 Immunization Excellence Awards in "Healthcare Personnel Campaign" category

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, was recognized at the National Adult and Influenza Immunization Summit (NAIIS) as the national winner in the "Healthcare Personnel Campaign" category of the 2014 Immunization Excellence Awards.

14 May 2014

Study reveals sea salt and table salt have equivalent sodium content

Pink Himalayan, Breton Gray and Hawaiian Alea - the newer offerings of salt may be exotic, cost more and frequent the shelves of high-end stores, but they are just as bad for you as common table salt.

14 May 2014

SGK1 enzyme, asthma and cancer therapies: an interview with Dr. Jonathan D. Powell, Johns Hopkins Kimmel Cancer Center

SGK1 stands for serum/glucocorticoid-regulated kinase 1. SGK1 is a member of the AGC kinase family, which is a huge family of kinases.

13 May 2014

Inflammation may accentuate age-related bladder function decline

Age-associated biochemical changes in the bladder may accentuate the inflammation associated with overactive bladder, study findings indicate.

12 May 2014

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.

12 May 2014

New drug approach for safer clean-up of deformed blood vessels in eye

A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.

12 May 2014

Nephrology News and Research

Further Reading

Presentation at NMS 2014 highlights growing dangers of non-steroidal anti-inflammatory drugs

Researchers resolve long-standing mystery of enzyme's role in cell survival

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

Kidney transplant recipients live longer than patients on intensive home hemodialysis

St. Jude Medical's EnligHTN renal denervation system safe, effective for treating drug-resistant hypertension

Professor receives grant to study stress-induced hypertension, its effects on neuroimmune system

New drug offers promising possibility for treating adults with periodontitis

Renal dysfunction affects NT-proBNP predictive thresholds in pulmonary hypertension

Low risk prostate cancer not always low risk

First Edition: May 16, 2014

Bristol-Myers Squibb announces study results of nivolumab drug in patients with renal cell carcinoma

Walking shown to improve clinical outcomes in patients with kidney disease

OxThera granted new patents for treatment of hyperoxaluria

Fourteen businesses receive innovative funding to improve kidney care

DaVita wins 2014 Immunization Excellence Awards in "Healthcare Personnel Campaign" category

Study reveals sea salt and table salt have equivalent sodium content

SGK1 enzyme, asthma and cancer therapies: an interview with Dr. Jonathan D. Powell, Johns Hopkins Kimmel Cancer Center

Inflammation may accentuate age-related bladder function decline

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

New drug approach for safer clean-up of deformed blood vessels in eye

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News